Geneos Wealth Management’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-120
| Closed | -$1.01K | – | 3081 |
|
|
2024
Q4 | $1.01K | Buy |
120
+7
| +6% | +$59 | ﹤0.01% | 2766 |
|
|
2024
Q3 | $2.43K | Sell |
113
-850
| -88% | -$18.3K | ﹤0.01% | 2255 |
|
|
2024
Q2 | $21.9K | Hold |
963
| – | – | ﹤0.01% | 1315 |
|
|
2024
Q1 | $43.1K | Sell |
963
-50
| -5% | -$2.24K | ﹤0.01% | 1118 |
|
|
2023
Q4 | $63.6K | Hold |
1,013
| – | – | ﹤0.01% | 989 |
|
|
2023
Q3 | $73.7K | Buy |
1,013
+425
| +72% | +$30.9K | ﹤0.01% | 965 |
|
|
2023
Q2 | $37.6K | Hold |
588
| – | – | ﹤0.01% | 1167 |
|
|
2023
Q1 | $20.9K | Hold |
588
| – | – | ﹤0.01% | 1334 |
|
|
2022
Q4 | $13.9K | Hold |
588
| – | – | ﹤0.01% | 1442 |
|
|
2022
Q3 | $21K | Sell |
588
-448
| -43% | -$16K | ﹤0.01% | 1303 |
|
|
2022
Q2 | $53K | Buy |
1,036
+212
| +26% | +$10.8K | ﹤0.01% | 1255 |
|
|
2022
Q1 | $56K | Buy |
824
+100
| +14% | +$6.8K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $59K | Buy |
724
+280
| +63% | +$22.8K | ﹤0.01% | 1400 |
|
|
2021
Q3 | $49K | Buy |
444
+8
| +2% | +$883 | ﹤0.01% | 1501 |
|
|
2021
Q2 | $58K | Buy |
+436
| New | +$58K | ﹤0.01% | 1403 |
|